What is the global market size of Oral Solid Dosage Pharmaceutical Formulation Market?

Global Oral Solid Dosage Pharmaceutical Formulation Market size was valued at USD 555.3 billion in 2021 and is poised to grow from USD 606.6 billion in 2022 to USD 1000 billion by 2030, at a CAGR of 6.4% during the forecast period (2023-2030).

What is the key driver of Global Oral Solid Dosage Pharmaceutical Formulation Market?

Innovations such as 3D printing, nanotechnology, and improved drug delivery systems are enhancing the efficiency and effectiveness of oral solid dosage medications. These advancements not only improve patient compliance but also enable pharmaceutical companies to develop novel formulations, driving market growth.

Which region accounted for the largest share in Global Oral Solid Dosage Pharmaceutical Formulation Market?

North America is currently the dominating region in the Global Oral Solid Dosage Pharmaceutical Formulation Market. This dominance can be attributed to factors such as a well-established healthcare infrastructure, robust pharmaceutical industry, high healthcare spending, and a strong focus on research and development. The presence of major pharmaceutical companies and favorable regulatory policies further contribute to North America's leadership in this market.

Oral Solid Dosage Pharmaceutical Formulation Market Size, Share, Growth Analysis, By Product type(Tablets (Conventional/Immediate Release, Modified Release, Chewable Tablets, Effervescent Tablets)), By Mechanism(Controlled-release, Immediate-release, and Delayed-release), By End-user(Large-size Companies, Medium- & Small-size Companies, Others (Startups & Generic Pharmaceutical Companies)), By Region - Industry Forecast 2024-2031

Q: What is the key market trend for Global Oral Solid Dosage Pharmaceutical Formulation Market?

Personalized Medicine and Tailored Formulations : Advances in genetic profiling and biomarker identification have allowed pharmaceutical companies to develop medications customized to individual patient needs. This trend not only enhances treatment outcomes but also promotes patient adherence, leading to the development of niche markets for precision oral solid dosage formulations. As the healthcare industry continues to prioritize patient-centric approaches, the demand for personalized oral solid dosage medications is expected to rise significantly.

Report ID: SQMIG35I2306 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 95 | Figures: 71

Oral Solid Dosage Pharmaceutical Formulation Market News

April 2023: Eli Lilly and Company announced the launch of its new bilayer tablet formulation of Trulicity (dulaglutide) for the treatment of type 2 diabetes.
May 2023: AstraZeneca plc announced the launch of its new once-daily oral tablet formulation of Farxiga (dapagliflozin) for the treatment of type 2 diabetes and heart failure with preserved ejection fraction.
June 2023: Novartis AG announced the launch of its new extended-release tablet formulation of Vytorin (ezetimibe and simvastatin) for the treatment of high cholesterol.

Oral Solid Dosage Pharmaceutical Formulation Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Oral Solid Dosage Pharmaceutical Formulation Market size was valued at USD 606.6 Billion in 2022 and is poised to grow from USD 645.42 Billion in 2023 to USD 1060.17 Billion by 2031, at a CAGR of 6.4% during the forecast period (2024-2031).

The competitive landscape in the Global Oral Solid Dosage Pharmaceutical Formulation Market is characterized by intense rivalry among pharmaceutical companies striving to capture a significant market share. 'Catalent, Inc. (US)', 'Lonza Group (UK)', 'Piramal Pharma Solutions (India)', 'Aenova (Germany)', 'Jubilant (India)', 'Boehringer Ingelheim (Germany)', 'AbbVie Contract Manufacturing (US)', 'Patheon (US)', 'Recipharm (Sweden)', 'Next Pharma AB (Sweden)', 'Siegfried AG (Switzerland)', 'Corden Pharma (Switzerland)', 'Famar (Greece)', 'Alkermes (Ireland)', 'Hetero Labs Limited (India)'

Innovations which includes 3-D printing, nanotechnology, and stepped forward drug delivery systems are enhancing the performance and effectiveness of oral strong dosage medicinal drugs. These advancements no longer only improve affected person compliance but additionally enable pharmaceutical corporations to broaden novel formulations, using market boom.

Personalized Medicine and Tailored Formulations: Advances in genetic profiling and biomarker identification have allowed pharmaceutical companies to develop medications customized to individual patient needs. This trend not only enhances treatment outcomes but also promotes patient adherence, leading to the development of niche markets for precision oral solid dosage formulations. As the healthcare industry continues to prioritize patient-centric approaches, the demand for personalized oral solid dosage medications is expected to rise significantly.

North America is presently the dominating vicinity in the Global Oral Solid Dosage Pharmaceutical Formulation Market. This dominance can be attributed to factors along with a well-hooked up healthcare infrastructure, sturdy pharmaceutical enterprise, high healthcare spending, and a strong recognition on research and development. The presence of most important pharmaceutical corporations and favorable regulatory guidelines similarly make contributions to North America's leadership in this market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Oral Solid Dosage Pharmaceutical Formulation Market News

Oral Solid Dosage Pharmaceutical Formulation Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Oral Solid Dosage Pharmaceutical Formulation Market?

Who are the key vendors in the Oral Solid Dosage Pharmaceutical Formulation Market?

What is the key driver of Oral Solid Dosage Pharmaceutical Formulation Market?

What is the key market trend for Oral Solid Dosage Pharmaceutical Formulation Market?

Which region accounted for the largest share in Oral Solid Dosage Pharmaceutical Formulation Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300